Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Analyzing Stability Data for Gel Formulations – V 2.0

Posted on By

Gel Manufacturing: SOP for Analyzing Stability Data for Gel Formulations – V 2.0

Standard Operating Procedure for Analyzing Stability Data of Gel Formulations


Department Gel Manufacturing
SOP No. SOP/GM/105/2025
Supersedes SOP/GM/105/2022
Page No. Page 1 of 10
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2026

1. Purpose

This SOP provides a structured method for the statistical and trend analysis of stability data generated from gel formulation studies to determine product shelf-life and regulatory compliance.

2. Scope

This SOP applies to all gel-based pharmaceutical products undergoing stability studies in the Gel Manufacturing

and Quality Control departments.

3. Responsibilities

  • QC Analyst: Collects and compiles raw data from stability studies.
  • Stability Coordinator: Reviews and organizes data, performs trend analysis, and prepares reports.
  • QA Officer: Verifies data integrity, approves reports, and ensures compliance with guidelines.

4. Accountability

The Head – Quality Assurance is accountable for ensuring the stability data analysis is conducted accurately and documented as per regulatory requirements.

See also  Gel Manufacturing: SOP for Preparing Stability Study Reports for Regulatory Submissions - V 2.0

5. Procedure

5.1 Data Compilation

  1. Collect all raw data points from physical, chemical, microbiological, and functional tests conducted at each time point (e.g., 0, 1, 3, 6, 9, 12, 18, 24 months).
  2. Ensure the data is compiled in the Stability Data Compilation Template (Annexure-1).

5.2 Data Validation

  1. Check for missing entries, data duplication, transcription errors, or unit inconsistencies.
  2. Ensure outliers are investigated and supported with deviation records if retained.

5.3 Statistical Analysis

  1. Conduct trend analysis using graphical tools such as line charts, control charts, and regression curves.
  2. Calculate slope, confidence intervals, and mean degradation rate for assay and other key attributes.
  3. Determine shelf-life based on significant change or degradation threshold as per ICH guidelines.

5.4 Evaluation Criteria

  1. Compare all test parameters (assay, pH, viscosity, microbial count, appearance) against specification limits.
  2. Evaluate if any critical quality attribute falls outside acceptable range over time.
  3. Assess if accelerated condition data supports extrapolation of long-term stability claims.
See also  Gel Manufacturing: SOP for Calibration of Quality Control Instruments - V 2.0

5.5 Report Preparation

  1. Summarize findings in the Stability Analysis Report Template (Annexure-2).
  2. Include interpretation, graphical representation, and statistical tables in the report.
  3. Attach signed data sets and cross-reference sample IDs and time points.

5.6 Review and Approval

  1. QA will review the analysis report and verify all conclusions and calculations.
  2. Discrepancies or observations will be communicated for clarification or revision.
  3. Upon final approval, the report will be archived and referenced for regulatory submissions.

6. Abbreviations

  • QA: Quality Assurance
  • QC: Quality Control
  • ICH: International Council for Harmonisation
  • RSD: Relative Standard Deviation

7. Documents

  1. Stability Data Compilation Template – Annexure-1
  2. Stability Analysis Report Template – Annexure-2
  3. Trend Analysis Summary Sheet – Annexure-3

8. References

  • ICH Q1E – Evaluation for Stability Data
  • ICH Q1A(R2) – Stability Testing of New Drug Substances and Products
  • Schedule M – Good Manufacturing Practices
See also  Gel Manufacturing: SOP for Equipment Swab Testing for Cleaning Effectiveness - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Stability Data Compilation Template


Time Point Assay (%) pH Viscosity (cP) Microbial Count Appearance
0 Month
1 Month
3 Month

Annexure-2: Stability Analysis Report Template

Section Details
Batch Number
Storage Condition
Study Duration
Statistical Summary
Graphs Attached Yes/No
Deviation Remarks
Conclusion

Annexure-3: Trend Analysis Summary Sheet

Parameter Trend Observed Compliance Remarks
Assay Yes/No
pH Yes/No
Viscosity Yes/No
Microbial Load Yes/No

Revision History

Revision Date Revision No. Change Description Reason Approved By
01/06/2022 1.0 Initial SOP implementation New Product Launch QA Head
02/06/2025 2.0 Added statistical tools and revised annexures Compliance Update QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Batch Release of Injectable Products – V 2.0
Next Post: Elixir Department: SOP for Use of Jacketed Heating Tanks – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version